BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14109847)

  • 21. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of maple syrup urine disease by determination of L-valine, L-isoleucine, L-leucine and L-phenylalanine in neonatal blood spots by gas chromatography-mass spectrometry.
    Deng C; Deng Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):261-8. PubMed ID: 12860033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family].
    Sander C; Clotten R; Noetzel H; Wehinger H
    Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843
    [No Abstract]   [Full Text] [Related]  

  • 24. Leucine equivalency system in managing branched chain ketoaciduria.
    Smith BA; Waisman HA
    J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
    [No Abstract]   [Full Text] [Related]  

  • 25. [Maple syrup urine disease with an intermittent relatively benign course].
    Müller H; Bickel H; Feist D; Lutz P
    Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339
    [No Abstract]   [Full Text] [Related]  

  • 26. M aple syrup urine disease. A review with a report of an additional case.
    Schwartz JF; Kolendrianos ET
    Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351
    [No Abstract]   [Full Text] [Related]  

  • 27. Maple syrup urine disease in an infant with microgyria.
    Martin JK; Norman RM
    Dev Med Child Neurol; 1967 Apr; 9(2):152-9. PubMed ID: 6059316
    [No Abstract]   [Full Text] [Related]  

  • 28. Maple syrup urine disease variant: report on an infant.
    Koepp P; Rybak C; Rüdiger HW; Wendel U
    Z Kinderheilkd; 1974 Feb; 116(3):177-84. PubMed ID: 4813457
    [No Abstract]   [Full Text] [Related]  

  • 29. [On prolonged diet-therapy of an infant with urinary valine and leucine disorders associated with mental retardation (maple syrup urine disease)].
    Schmidt GW; Benecke G; Peiffer J
    Helv Paediatr Acta; 1965 Jun; 20(2):147-68. PubMed ID: 5834532
    [No Abstract]   [Full Text] [Related]  

  • 30. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A; Narojek L; Sykut-Cegielska J
    Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
    Irwin WC; Martel SB; Goluboff N
    Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296
    [No Abstract]   [Full Text] [Related]  

  • 32. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
    Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
    Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings: Neonatal diagnosis of maple syrup urine disease and the influence of exchange blood transfusion.
    Russell A; Statter M; Shina A; Perlman M
    Isr J Med Sci; 1975 Nov; 11(11):1218-9. PubMed ID: 1205813
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dietetics in hereditary enzyme deficiencies].
    Royer P
    Sem Hop; 1970 Feb; 46(10):653-9. PubMed ID: 4314674
    [No Abstract]   [Full Text] [Related]  

  • 35. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
    Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
    Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine).
    Mogoş T; Cheţa CP; Mincu IT
    Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of maple syrup disease. Clinical and electroencephalographic observations with dietetic experiment. Critical review of literature].
    Grossi-Bianchi ML; Gatti R; Marchi AG
    Minerva Pediatr; 1967 Aug; 19(33):1552-65. PubMed ID: 4889027
    [No Abstract]   [Full Text] [Related]  

  • 38. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Maple syrup urine disease].
    Incesu L; Tasdemir HA; Yazicioglu AK; Belet U; Danaci M
    Radiol Med; 2001 Sep; 102(3):194-6. PubMed ID: 11677467
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of the acute crisis in maple syrup urine disease.
    Nyhan WL; Rice-Kelts M; Klein J; Barshop BA
    Arch Pediatr Adolesc Med; 1998 Jun; 152(6):593-8. PubMed ID: 9641714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.